ACAmbar Noemi Armijos Cevallos

Ambar Noemi Armijos Cevallos

*This is an algorithmically generated author record based on publicly available information.

Ambar Noemi Armijos Cevallos has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Osteomyelitis of the Maxilla Secondary to Periorbital Cellulitis in a Neonate: A Case Report

    by Jean Carlos Delgado Macías, Miguel Ángel Hernández Cedeño, Ambar Noemi Armijos Cevallos, Alex Villalta Herrera, Auror Chávez Veliz, Reyma Mosquera Peña

    Osteomyelitis is an infection of bone tissue and bone marrow, primarily caused by bacteria, which may spread through three main routes: hematogenous dissemination, contiguous spread, or direct inoculation. In the neonatal period, it represents a rare but severe condition with the potential to cause permanent osteoarticular sequelae. During this stage of life, osteomyelitis exhibits etiopathogenic and histological features that differ from those observed in other age groups. Involvement of the facial skeleton is uncommon and is usually secondary to contiguous soft tissue infections of the face. We report the case of a 20-day-old female neonate who developed osteomyelitis of the maxilla secondary to facial and periorbital cellulitis, with Staphylococcus aureus isolated from blood cultures and ocular discharge. The patient was treated with broad-spectrum antibiotic therapy and conservative surgical management, showing favorable clinical evolution and currently remaining under outpatient follow-up

  • Open Access

    Trombosis de vena porta en etapa neonatal. Reporte de caso

    by Ambar Armijos, Brigitte Secaira, Daniel Kwiek, Reyma Mosquera, Elena Crespo, David Rosas, Alex Villalta

    Thrombotic events in neonates are rare pathologies associated with the use of umbilical catheters. Venous thromboses, especially portal vein thrombosis (DVT), are more common than arterial ones. They can extend to the intrahepatic portal branches and cause serious complications, such as portal hypertension. Early detection and timely treatment are essential to avoid serious complications. We present the case of a preterm neonate transferred at two days of age, who had an umbilical catheter placed for venous support in the hospital of origin. During hospitalization, an imaging study was performed for signs of cholestasis, finding an image suggestive of thrombosis in the left branch of the portal vein. The diagnosis was confirmed by Doppler ultrasound and triphasic tomography. Treatment was initiated with low molecular weight heparin as an anticoagulant. After the start of treatment, a decrease in bilirubin levels and progressive improvement of clinical signs will be observed. There were no serious complications such as portal cavernomatosis or portal hypertension and the patient had a favorable evolution without requiring surgical intervention. Thrombosis associated with umbilical catheter in neonates is a rare complication, but with high morbidity. Early diagnosis through imaging studies and initiation of early anticoagulant therapy are crucial to improve prognosis and avoid serious complications.

  • Open Access

    Beneficios del Uso Temprano del Oxígeno de Alto Flujo como Reductor de Estancia Hospitalaria en Pacientes Menores de 2 Años con Diagnóstico de Bronquiolitis

    by José Roberto Rodriguez Mera, Juan Gregorio Chang Asinc, Miryam Paola Troya Toro, Cristina Isabel Barahona Moreta, Ambar Noemi Armijos Cevallos, Natalia Fiorella Loor Reyes

    Introducción: La bronquiolitis se define como aquella patología respiratoria que afecta a las vías respiratorias inferiores con un número mayor de casos en pacientes menores de 1 año y que ocupa un gran porcentaje de ingresos hospitalarios. El uso del oxígeno de alto flujo (OAF) aporta un flujo de oxígeno, humidificado y caliente que ayuda a reducir la progresión de los efectos graves en aquellos pacientes con bronquiolitis, mejorando la oxigenación y eliminación del dióxido de carbono. Objetivo: Determinar el beneficio del uso de los dispositivos de alto flujo como reductor de estancia hospitalaria en pacientes menores de dos años con diagnóstico bronquiolitis. Pacientes y métodos: Se realiza un estudio observacional, descriptivo, analítico y retrospectivo de casos diagnosticados con bronquiolitis, los mismos que se han detectado en el área de emergencia del Hospital Roberto Gilbert Elizalde, en el periodo de tiempo de mayo 2022 a mayo del 2023. Resultados: En el periodo de mayo del 2022 a mayo del 2023, se encontraron 478 pacientes entre 0 y 2 años con diagnóstico de bronquiolitis, de los cuales 121 utilizaron como tratamiento OAF (25.3%), 95 fueron tomados para realiza nuestro estudio, de ellos 51 niños afectados (53.6%), 74 pacientes (77.9%) con crisis moderadas que se sometieron a la OAF, 77 de ellos usaron esta terapéutica en las primeras 10 horas de ingreso (81.05%), con una estancia hospitalaria en su mayoría entre 7 a 12 días (49.3%).